Geode Capital Management
AGN

Geode Capital Management’s Allergan Inc AGN Stock Holding History

Geode Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,162,893
Closed -$459M – 4057
2014
Q4 		$459M Buy
2,162,893
+90,296
+4% +$18M 0.27% 80
2014
Q3 		$369M Sell
2,072,597
-23,719
-1% -$3.94M 0.24% 89
2014
Q2 		$355M Sell
2,096,316
-28,217
-1% -$4.39M 0.23% 89
2014
Q1 		$264M Buy
2,124,533
+11,761
+0.6% +$1.43M 0.18% 114
2013
Q4 		$235M Buy
2,112,772
+61,683
+3% +$5.89M 0.16% 128
2013
Q3 		$185M Buy
2,051,089
+57,689
+3% +$5.18M 0.15% 136
2013
Q2 		$168M Buy
+1,993,400
New +$207M 0.15% 134

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Geode Capital Management's AGN Position: Q1 2015 in Review

Geode Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,162,893 shares — an estimated $459M sold.

Geode Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $459M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Geode Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Geode Capital Management sold 2,162,893 Allergan Inc shares in Q1 2015, an estimated $459M.
  • Geode Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Geode Capital Management's Allergan Inc position peaked at $459M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Geode Capital Management's 13F filing for Q1 2015, filed 14 May 2015.